Skip to main content

Table 2 Vital signs and laboratory studies of the studied group before and after using sotrovimab

From: Sotrovimab: is it effective in early treatment of mild and moderate COVID-19 infections? A retrospective study

 

Before sotrovimab

After sotrovimab

Paired t test

p value

Temperature

38.008±0.886

37.633±0.855

4.504

0.001*

Pulse

78.714±16.573

73.168±12.419

3.739

0.001*

RR

24.196±7.881

21.050±6.421

4.287

0.001*

WBCs

5626.818±2343.335

6249.546±2440.329

− 4.104

0.001*

Lymphocytes

1.829±0.740

2.083±0.801

− 3.709

0.001*

CRP

52.885±47.854

43.255±56.209

2.621

0.009*

D-dimer

1.880±1.611

2.956±4.097

− 3.750

0.001*

UREA

9.291±4.225

4.532±2.307

16.716

0.001*

Creatinine

158.591±95.976

68.314±19.915

14.137

0.001*

GFR

56.655±25.876

96.350±15.764

− 22.200

0.001*

NA

144.150±5.397

139.027±4.092

12.905

0.001*

K

4.804±1.198

4.219±0.258

6.857

0.001*

Ca

1.930±0.166

2.340±0.145

− 30.727

0.001*

Mg

0.841±0.102

1.006±0.066

− 29.099

0.001*

Phosphorus

0.903±0.171

1.106±0.217

− 22.069

0.001*

Glucose

13.226±3.966

9.091±2.142

13.751

0.001*

TSH

2.275±1.536

2.020±1.545

3.999

0.001*

Free t4

14.662±2.214

14.282±2.792

2.767

0.006*

ALT

113.232±102.281

66.377±61.647

5.791

0.001*

AST

73.723±64.139

40.518±18.064

7.283

0.001*

Albumin

19.446±4.848

33.523±6.588

− 32.492

0.001*

  1. SD standard deviation
  2. *Significant